uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
beta-cell specific overexpression of suppressor of cytokine signalling-3 does not protect against multiple low dose streptozotocin induced type 1 diabetes in mice
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Cell Biology.
Show others and affiliations
2011 (English)In: Immunology Letters, ISSN 0165-2478, E-ISSN 1879-0542, Vol. 136, no 1, 74-79 p.Article in journal (Refereed) Published
Abstract [en]

We investigated the impact of beta-cell specific overexpression of suppressor of cytokine signalling-3 (SOCS-3) on the development of multiple low dose streptozotocin (MLDSTZ) induced Type 1 diabetes and the possible mechanisms involved. MLDSTZ treatment was administered to RIP-SOCS-3 transgenic and wild-type (wt) mice and progression of hyperglycemia monitored. Isolated islets from both strains were exposed to human IL-1 beta (25 U/ml) or a combination of human IL-1 beta (25 U/ml) and murine IFN-gamma (1000 U/ml) for 24h or 48h and we investigated the expression of IL-1 receptor antagonist (IL-1Ra) mRNA in islet cells and secretion of IL-1Ra into culture medium. MLDSTZ treatment caused gradual hyperglycemia both in the wt mice and in the transgenic mice with the latter tending to be more sensitive. In vitro experiments on wt and transgenic islets did not reveal any differences in sensitivity to damaging effects of STZ. Exposure of wt islets to 1L-1 beta or IL-1 beta + IFN-gamma seemed to lead to a failing IL-1Ra response from SOCS-3 transgenic islets. It could be that an increased expression of a possible protective molecule against beta-cell destruction may lead to a dampered response of another putative protective molecule. This may have counteracted a protective effect against MLDSTZ in SOCS-3 transgenic mice.

Place, publisher, year, edition, pages
2011. Vol. 136, no 1, 74-79 p.
Keyword [en]
Type 1 diabetes, Interleukin, IL-1Ra (IL-1 receptor antagonist), SOCS (suppressor of cytokine signalling)
National Category
Medical and Health Sciences
URN: urn:nbn:se:uu:diva-151981DOI: 10.1016/j.imlet.2010.12.007ISI: 000289134400010PubMedID: 21237203OAI: oai:DiVA.org:uu-151981DiVA: diva2:411930
Available from: 2011-04-20 Created: 2011-04-20 Last updated: 2011-04-20Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed
By organisation
Department of Medical Cell Biology
In the same journal
Immunology Letters
Medical and Health Sciences

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Altmetric score

Total: 146 hits
ReferencesLink to record
Permanent link

Direct link